XRAY vs ABBV: Which Stock is Better?
Side-by-side comparison of Dentsply Sirona Inc and AbbVie Inc in 2026
XRAY
Dentsply Sirona Inc
—
ABBV
AbbVie Inc
$248.08
Key Metrics Comparison
| Metric | XRAY | ABBV | Winner |
|---|---|---|---|
| Market Cap | $2.01B | $334.34B | ABBV |
| P/E Ratio | N/A | 80.54 | ABBV |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze XRAY
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is XRAY or ABBV a better investment?
Comparing XRAY and ABBV: Dentsply Sirona Inc has a market cap of $2.01B while AbbVie Inc has $334.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between XRAY and ABBV?
XRAY (Dentsply Sirona Inc) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: XRAY or ABBV?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: XRAY or ABBV?
Both XRAY and ABBV show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: XRAY or ABBV?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: XRAY or ABBV?
AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $2.01B for XRAY.
Should I buy XRAY or ABBV in 2026?
Both XRAY and ABBV have investment merit. XRAY trades at $N/A while ABBV trades at $248.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between XRAY and ABBV stock?
Key differences: Market Cap ($2.01B vs $334.34B), P/E Ratio (N/A vs 80.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy XRAY or ABBV in 2026?
The choice between XRAY and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.0%). ABBV has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between XRAY and ABBV?
XRAY (Dentsply Sirona Inc) has a market cap of $2.01B, while ABBV (AbbVie Inc) has a market cap of $334.34B. ABBV is the larger company by market value.